OVERVIEW

Investigating efficacy of extended-release steroid FX006 16mg and 32mg in knee OA treatment is organized by OrthoEvidence Inc. 

Additional details will be posted as soon as they are available.

Credits
  • 0.5 CME
  • TARGET AUDIENCE

    RheumatologistsOrthopedics

    SPECIALITIES

    OrthopedicsRheumatology